Dr Matthew D Dellinger, DMD in Cullman, AL - Medicare Dentist Provider

Dr Matthew D Dellinger, DMD is a medicare enrolled "Dentist" provider in Cullman, Alabama. His current practice location is 210 Main Ave Nw, Cullman, Alabama. You can reach out to his office (for appointments etc.) via phone at (256) 734-2860.

Dr Matthew D Dellinger is licensed to practice in Alabama (license number 5768) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1538489018.

Contact Information

	Dr Matthew D Dellinger, DMD
	210 Main Ave Nw, Cullman, AL 35055-2896
	(256) 734-2860
	(256) 734-1094

Healthcare Provider's Profile

Full Name	Dr Matthew D Dellinger
Gender	Male
Speciality	Dentist
Location	210 Main Ave Nw, Cullman, Alabama
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1538489018
Provider Enumeration Date: 06/07/2010
Last Update Date: 06/07/2010

Medicare PECOS Information:

PECOS PAC ID: 4284934043
Enrollment ID: I20151130001190

Medical Identifiers

Medical identifiers for Dr Matthew D Dellinger such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1538489018	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
122300000X	Dentist	5768 (Alabama)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Matthew D Dellinger is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Matthew D Dellinger, DMD 210 Main Ave Nw, Cullman, AL 35055-2896 Ph: (256) 734-2860	Dr Matthew D Dellinger, DMD 210 Main Ave Nw, Cullman, AL 35055-2896 Ph: (256) 734-2860

News Archive

FDA looks for feedback on Medication Guide program

The Food and Drug Administration (FDA) will hold a public hearing on June 12 and 13, 2007, to obtain feedback on FDA's Medication Guide program.

MAQUET Cardiovascular commences enrollment in trial of FUSION and FUSION BIOLINE Vascular Grafts

MAQUET Cardiovascular LLC today announced enrollment of the first patient in FINEST (FUSION Vascular Graft, FUSION Vascular Graft with BIOLINE and EXXCEL SOFT ePTFE). This prospective, randomized, single-blind, three-arm, parallel group, multi-center study is evaluating the safety and efficacy of MAQUET's investigational FUSION Vascular Graft and FUSION BIOLINE Vascular Graft, compared with its commercially available EXXCEL Soft ePTFE Vascular Graft in peripheral artery bypass surgery.

HORIZONS-AMI clinical trial demonstrates efficacy of drug-eluting stent

Late-breaking data from the landmark HORIZONS-AMI clinical trial, presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrated that after two years, in heart attack patients, the use of a drug-eluting stent (paclitaxel) was safer and more effective than a bare-metal stent; and that the administration of the anticoagulant medication bivalirudin enhanced safety and efficacy compared to the use of heparin + GPIIb/IIIa inhibitors.

B2Discovery rallies business leaders in support of excellence in cancer research

The Institute for Research in Immunology and Cancer (IRIC) of the Universit- de Montr-al launches B2Discovery, a new research funding model that brings together the private sector and the biomedical research community to help accelerate the discovery of new anti-cancer therapeutics. Inspired by B2ten, which contributed to the success of several Canadian athletes at the Vancouver Winter Olympics, B2Discovery's mission is to partner entrepreneurs with IRIC's cancer investigators to finance novel and promising research projects not currently funded by public granting agencies.

Study confirms MammaPrint's capabilities in determining patients likely to benefit from chemotherapy

Today, at the 11th Annual Meeting of the American Society of Breast Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced that Breast Cancer Research and Treatment has published an important study demonstrating the benefit of adjuvant chemotherapy for patients with a high-risk of breast cancer recurrence according to the MammaPrint test. The ASBS meeting takes places April 28 - May 2, 2010, at the Bellagio in Las Vegas, where you can meet the Agendia team at booth # 314.

Dentist in Cullman, AL

Dr. Michael James Graham, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 406 3rd Ave Ne, Cullman, AL 35055 Phone: 256-739-6418 Fax: 256-739-9529
Dr. Cristina Piazza Burkes, D.M.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 704 2nd Ave Sw, Cullman, AL 35055 Phone: 256-739-5533
Dr. Joshua Michael Robinson, D.M.D., M.S.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1851 Main Ave Se, Suite A, Cullman, AL 35055 Phone: 256-737-9838 Fax: 256-737-9839
Dr. Abigail Nelson Diluzio, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 205 4th Ave Ne Ste 101, Cullman, AL 35055 Phone: 256-739-5533
Dr. Thomas Allan Barnes, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 704 2nd Ave Sw, Cullman, AL 35055 Phone: 256-739-5533 Fax: 256-739-0177
Dr. Ralph Kurry Wyatt, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 307 Elizabeth St Ne, Cullman, AL 35055 Phone: 256-734-1866 Fax: 256-734-1869
Dr. Mitzi M. Wade, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2016 Main Ave Sw, Cullman, AL 35055 Phone: 256-775-0230 Fax: 256-735-0943

Dr Matthew D Dellinger, DMD - Medicare Dentist in Cullman, AL